Medicines Recalled - Lack of Assurance of Sterility

A voluntary recall has been issued for certain doses of GLP-1 medications Mounjaro and Zepbound due to “a lack of assurance of sterility.” The affected products, manufactured and distributed by Apothecary Pharma LLC, involve the active ingredient tirzepatide. According to the recall notice, almost two dozen lots are included. The recalled items were sold by prescription only in 18mg/mL and 4mL sterile, multi-dose vials. The FDA classified the action as a Class II recall, indicating possible health risks, though dangerous consequences are considered unlikely. Patients are directed to compare lot numbers with the FDA list and contact the manufacturer with questions.